← Oncology Approval Tracker

FDA DECISION ·

Bendamustine hydrochloride injection

bendamustine hydrochloride · Dr. Reddy’s Laboratories

FDA approvalNew formulationChronic lymphocytic leukemia and indolent B-cell lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

For adults with CLL or with indolent B-cell non-Hodgkin lymphoma that progressed during or within 6 months after rituximab or a rituximab-containing regimen.

LAMPGEN ANALYSIS

Why it matters

FDA approved a separate bendamustine injection product under an original NDA for these established uses.

What research teams should watch

Use product-specific vial, dilution, and infusion instructions and preserve blood count and tumor lysis monitoring.

PRIMARY RECORDS

Sources